• Urology
  • Uro-oncology

Areas of interest

Benign Prostatic Hyperplasia (BPH), Focal therapy for Prostate Cancer


Prof Mark Frydenberg specialises in urological cancer management, assessment of haematuria and raised PSA, management of benign prostate disease. Urologic Oncology Fellow Mayo Clinic 1991/2, Chairman, Department of Urology Monash Health 1997-2017, President Urological Society of Australia and New Zealand 2015-2017, Urology Council member, Royal Australasian College of Surgeons 2017 to present, Academic Director of Urology, Cabrini Health 2019 to present, Board member Peninsula Health. Published in excess of 235 peer reviewed articles as of July 2021, was awarded an AM for services to medicine in 2016.

Consulting locations

Consulting Location

Ground Floor
322 Glenferrie Road
Malvern VIC 3144

Consulting Location

Suite 21
Isabella Street
Malvern VIC 3144

Epworth locations


Epworth Richmond


  • MBBS University of Melbourne
  • FRACS (Urology) 1991
  • Fellowship - Urologic Oncology, Mayo Clinic, Rochester, Minnesota, USA


  • Published > 235 peer reviewed articles as of July 2021

Professional Associations

  • Urological Society of Australia and New Zealand
  • Society of Urologic Oncology
  • American Urological Society
  • European Association of Urology
  • American Association of Genitourinary Surgeons
  • Urological Research Society

Public Appointments

  • Board member Peninsula Health
  • Bairnsdale Regional Health Service

We use cookies to provide you with a customised experience which may include marketing purposes. More details can be found at our Privacy Policy.